Literature DB >> 8948124

Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart.

T D O'Connell1, R U Simpson.   

Abstract

A number of recent clinical observations suggest that vitamin D3 plays an important role in maintaining normal cardiovascular function, either directly through its receptor in cardiac muscle, or indirectly through its influence on circulating levels of calcium or on other regulatory factors. By using an antibody directed against the recombinant vitamin D3 receptor, we have identified the receptor protein for 1,25(OH)2D3 in tissue from two human hearts. The identification of the 1,25(OH)2D3 receptor in human heart lends credence to the hypothesis that 1,25(OH)2D3 directly effects the human heart and may be involved in several clinically relevant pathological conditions involving the vitamin D3 endocrine system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948124     DOI: 10.1006/cbir.1996.0081

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  22 in total

1.  Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

Authors:  Pamela A Marshall; Zachary Hernandez; Ichiro Kaneko; Tim Widener; Christa Tabacaru; Izayadeth Aguayo; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-14       Impact factor: 4.292

Review 2.  Vitamin D and the heart.

Authors:  David G Gardner; Songcang Chen; Denis J Glenn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

3.  1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte.

Authors:  Karl A Nibbelink; Daniel X Tishkoff; Stephen D Hershey; Ayesha Rahman; Robert U Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-23       Impact factor: 4.292

4.  Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004.

Authors:  Michal L Melamed; Paul Muntner; Erin D Michos; Jaime Uribarri; Collin Weber; Jyotirmay Sharma; Paolo Raggi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-16       Impact factor: 8.311

5.  Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Mehmet Baha Aytaç; Murat Deveci; Kenan Bek; Özlem Kayabey; Zelal Ekinci
Journal:  Pediatr Nephrol       Date:  2015-10-02       Impact factor: 3.714

6.  Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants.

Authors:  M C Backström; R Mäki; A L Kuusela; H Sievänen; A M Koivisto; R S Ikonen; T Kouri; M Mäki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 7.  Vitamin D and cardiovascular disease: potential role in health disparities.

Authors:  Jorge N Artaza; Sandra Contreras; Leah A Garcia; Rajnish Mehrotra; Gary Gibbons; Ralph Shohet; David Martins; Keith C Norris
Journal:  J Health Care Poor Underserved       Date:  2011

8.  Impact of vitamin D3 on cardiovascular responses to glucocorticoid excess.

Authors:  Mona A Ahmed
Journal:  J Physiol Biochem       Date:  2012-09-19       Impact factor: 4.158

Review 9.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

10.  Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events.

Authors:  Sachiyo Sugiura; Daijo Inaguma; Akimitsu Kitagawa; Minako Murata; Yutaka Kamimura; Sho Sendo; Kyoko Hamaguchi; Hiroshi Nagaya; Miho Tatematsu; Kei Kurata; Yukio Yuzawa; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-10-31       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.